Nanomedicine as a potential novel therapeutic approach against the dengue virus
Dengue is an arbovirus infection which is transmitted by Aedes mosquitoes. Its prompt detection and effective treatment is a global health challenge. Various nanoparticle-based vaccines have been formulated to present immunogen (antigens) to instigate an immune response or prevent virus spread, but no specific treatment has been devised. This review explores the role of nanomedicine-based therapeutic agents against dengue virus, taking into consideration the applicable dengue virus assays that are sensitive, specific, have a short turnaround time and are inexpensive. Various kinds of metallic, polymeric and lipid nanoparticles with safe and effective profiles present an alternative strategy that could provide a better remedy for eradicating the dengue virus.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Nanomedicine (London, England) - 18(2023), 22 vom: 01. Sept., Seite 1567-1584 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zohra, Tanzeel [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 15.11.2023 Date Revised 22.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/nnm-2022-0217 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362500525 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362500525 | ||
| 003 | DE-627 | ||
| 005 | 20240423231958.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/nnm-2022-0217 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1384.xml |
| 035 | |a (DE-627)NLM362500525 | ||
| 035 | |a (NLM)37753727 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zohra, Tanzeel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nanomedicine as a potential novel therapeutic approach against the dengue virus |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.11.2023 | ||
| 500 | |a Date Revised 22.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Dengue is an arbovirus infection which is transmitted by Aedes mosquitoes. Its prompt detection and effective treatment is a global health challenge. Various nanoparticle-based vaccines have been formulated to present immunogen (antigens) to instigate an immune response or prevent virus spread, but no specific treatment has been devised. This review explores the role of nanomedicine-based therapeutic agents against dengue virus, taking into consideration the applicable dengue virus assays that are sensitive, specific, have a short turnaround time and are inexpensive. Various kinds of metallic, polymeric and lipid nanoparticles with safe and effective profiles present an alternative strategy that could provide a better remedy for eradicating the dengue virus | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a arbovirus | |
| 650 | 4 | |a calcium phosphate nanoparticle vaccine | |
| 650 | 4 | |a dengue infection | |
| 650 | 4 | |a dengue virus | |
| 650 | 4 | |a drug delivery | |
| 650 | 4 | |a nanomedicine | |
| 650 | 4 | |a nanoparticle-based vaccines | |
| 650 | 4 | |a nanotherapeutics | |
| 650 | 4 | |a nanovaccine | |
| 650 | 4 | |a therapeutic approach | |
| 700 | 1 | |a Saeed, Faryal |e verfasserin |4 aut | |
| 700 | 1 | |a Ikram, Aamer |e verfasserin |4 aut | |
| 700 | 1 | |a Khan, Tariq |e verfasserin |4 aut | |
| 700 | 1 | |a Alam, Siyab |e verfasserin |4 aut | |
| 700 | 1 | |a Adil, Muhammad |e verfasserin |4 aut | |
| 700 | 1 | |a Gul, Ayesha |e verfasserin |4 aut | |
| 700 | 1 | |a Almawash, Saud |e verfasserin |4 aut | |
| 700 | 1 | |a Ayaz, Muhammad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nanomedicine (London, England) |d 2006 |g 18(2023), 22 vom: 01. Sept., Seite 1567-1584 |w (DE-627)NLM17228452X |x 1748-6963 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2023 |g number:22 |g day:01 |g month:09 |g pages:1567-1584 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/nnm-2022-0217 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2023 |e 22 |b 01 |c 09 |h 1567-1584 | ||